No Data
No Data
Jarden Securities Upgrades Ebos Group to Overweight From Neutral, Price Target Is NZ$38.00
Ebos Group (NZE:EBO) has an average rating of hold and price targets ranging from NZ$30.50 to NZ$40.93, according to analysts polled by CapitalIQ.
Ebos Group Appoints New CFO
Ebos Group (NZE:EBO, ASX:EBO) has appointed Alistair Gray as chief financial officer effective Sept. 30, according to a Friday New Zealand bourse filing. The Australasian healthcare, medical and pharm
Ebos Group Declares DRP Strike Price for Interim Dividend
Healthcare products distributor Ebos Group (ASX:EBO, NZE:EBO) declared a strike price of NZ$35.65 per share for the shares to be issued under the dividend reinvestment plan (DRP) for its half-year div
Ebos Can Weather Loss of Chemist Warehouse Contract -- Market Talk
2339 GMT - Forsyth Barr says it's more confident that Ebos can navigate the loss of a big contract with Chemist Warehouse without significant downside to current FY 2025 consensus expectations. Repres
Morgan Stanley Adjusts EBOS Group's Price Target to AU$37 From AU$38, Keeps at Overweight
09:25 PM EST, 03/05/2024 (MT Newswires) -- Morgan Stanley Adjusts EBOS Group's Price Target to AU$37 From AU$38, Keeps at Overweight Price (AUD): $33.90, Change: $-0.43, Percent Change: -1.25%
Ebos Target Price Raised 3.8% to NZ$40.70/Share by Macquarie>EBO.NZ
Ebos Target Price Raised 3.8% to NZ$40.70/Share by Macquarie>EBO.NZ
No Data